Evaluation of Proton Therapy in Pediatric Cancer Patients
This is a Phase IV clinical trial observing and evaluating the safety of proton therapy in children. Protocol therapy is not being done as part of this clinical trial. The radiation targeting, planning, prescribed dose, fractionation, schedule, and use of other forms of therapy will be done per other therapeutic protocols at St. Jude Children's Research Hospital (SJCRH) at the discretion of the treating physicians associated with those trials.
Conditions:
🦠 Tumor
🗓️ Study Start (Actual) 1 August 2017
🗓️ Primary Completion (Estimated) July 2037
✅ Study Completion (Estimated) July 2037
👥 Enrollment (Estimated) 1000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Memphis, Tennessee, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * The patient is planned for treatment or has been treated with proton therapy at St. Jude Children's Research Hospital on or after November 18, 2015.

    Exclusion Criteria:

    • * Patients who are currently pregnant will not be enrolled in the study as radiation has teratogenic or abortifacient effects. In the rare case that a patient was previously pregnant as a young adult, the patient will be considered eligible for enrollment.
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 18 July 2017
  • First Submitted that Met QC Criteria 18 July 2017
  • First Posted 21 July 2017

Study Record Updates

  • Last Update Submitted that Met QC Criteria 6 February 2024
  • Last Update Posted 7 February 2024
  • Last Verified February 2024